Emaretamig
Emaretamig is a humanized IgG1κ monoclonal antibody inhibitor targeting CLDN18 and CD3E. Abdakibart can be used for cancers like gastric and pancreatic cancer research[1].
Product Specifications
CAS Number
[3051701-97-1]
Product Name Alternative
ASP-2138
UNSPSC
12352100
Target
CD3; Claudin
Related Pathways
Cytoskeleton; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CLDN18
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C6205-HRP 100 µL
CNPase (2',3'-cyclic Nucleotide 3'-phosphodiesterase) (HRP) discontinued see C6205-01-HRP
Ask
View Details 
